In Focus, April 2008

Article

A round up of April's In Focus news

Please click on any of the headlines below to read the full story.

Ophthalmologists should encourage smoking cessationThere is a need to introduce smoking cessation support into routine ophthalmic practice, according to a report published in the February issue of Eye.

Vitreoretinal procedures should be treated as day casesPatients who are currently hospitalized overnight for vitreoretinal surgery could safely be treated as day cases, thus providing significant improvements in efficiency…

Computer model provides vital information about lens accommodationDuring accommodation, changes in lens thickness are mainly caused by deformation of the nucleus…

UK cataract dataset audit reveals medications more likely to cause complications during surgeryClopidogrel and warfarin are associated with a significant increase in minor complications of sharp needle and subtenon?s cannula local anaesthesia but are not associated with sight-threatening complications…

Corneal grafts from cancer patients more likely to cause infectionCorneal grafts obtained from cancer patients may be associated with an increased risk of infection for the recipient…

MICS in the Headlines…

MICS safer and more effective than torsional phacoThe new Custom Control Software on the MICS Millennium platform (Bausch & Lomb) results in less endothelial cell loss than torsional phacoemulsification performed on the Infiniti System (Alcon)…

MICS IOLs better than conventional IOLsMicroincision cataract surgery (MICS) intraocular lenses (IOLs) provide better patient outcomes, which are more like refractive surgery in terms of reduced postoperative astigmatism and minimal induced aberrations…

Whitestar can deal with even the hardest nucleiMicroincision cataract surgery (MICS) with the Whitestar ICE and CASE systems (AMO) can be performed safely and effectively even in the hardest nuclei…

Bimanual just as safe as coaxial surgeryRemoving cataracts using a bimanual microincision technique and implanting a traditional foldable intraocular lens (IOL) through a separate incision causes no more corneal astigmatism compared with a traditional coaxial technique using the same lens…

MICS and non-penetrating glaucoma surgery combination okayMicroincisional bimanual phacoemulsification and non-penetrating glaucoma surgery appears to be a safe option for patients with glaucoma and co-existing cataract…

MICS does not degrade optical quality of corneaMicroincision cataract surgery (MICS) does not degrade the optical quality of the cornea, however, it does introduce changes in coma and higher order aberrations…

Square incisions offer good stabilityA Czech study has found that 2.2 mm square clear corneal incisions for microcoaxial phacoemulsification are very stable and provide adequate postoperative sealing…

MICS+aspheric IOL = fewer corneal changesMicroincision cataract surgery (MICS) with implantation of an aspheric intraocular lens (IOL) through a 1.8 mm incision can minimize surgically-induced corneal and ocular aberrations and improve optical performance…

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.